Relatively high COX-2 expression levels have been observed in advanced-stage lung cancer with lymph node metastases [43], and further studies indicate that COX-2 overexpression is associated with angiogenesis [44] as well as tumor invasion and metastasis [45, 46]. The gene discussed is PTGS2; the disease is lung carcinoma.